Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound

American Heart Journal

Volumn 159, Issue 2, 2010, Pages 271-277

  Kubo, Takashi ^a   Maehara, Akiko ^a   Mintz, Gary S ^a   Garcia Garcia, Hector M ^b   Serruys, Patrick W ^b   Suzuki, Takahiko ^c   Klauss, Volker ^d   Sumitsuji, Satoru ^e   Lerman, Amir ^f   Marso, Steven P ^g   Margolis, M Pauliina ^h   Margolis, James R ⁱ   Foster, Michael C ^j   De Bruyne, Bernard ^k   Leon, Martin B ^a   Stone, Gregg W ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Toyohashi Heart Center Toyohashi   (Japan)

^d UNIVERSITY OF MUNICH   (Germany)

^e Nozaki Tokushukai Hospital   (Japan)

^f Mayo Clinic   (United States)

^g SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^h Volcano Corporation   (United States)

ⁱ Miami International Cardiology Consultants   (United States)

^j South Carolina Heart Center   (United States)

^k OLV HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CATHETER; COMPARATIVE STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; DYSLIPIDEMIA; FEMALE; HISTOLOGY; HUMAN; HYPERTENSION; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRTUAL REALITY;

CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 75449083415     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.11.008     Document Type: Article

References (17)

1. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Colombo A., Drzewiecki J., Banning A., et al. Randomized study to assess the effectiveness of slow- and moderate release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
3. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
4. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
5. Nair A., Kuban B.D., Tuzcu E.M., et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
6. Kim S.W., Mintz G.S., Hong Y.J., et al. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 102 (2008) 1182-1186
7. Klugherz B.D., Llanos G., Lieuallen W., et al. Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent. Coron Artery Dis 13 (2002) 183-188
8. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
9. Carter A.J., Aggarwal M., Kopia G.A., et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 63 (2004) 617-624
10. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
11. Nakazawa G., Finn A.V., Joner M., et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118 (2008) 1138-1145
12. Levin A.D., Vukmirovic N., Hwang C.W., et al. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci USA 101 (2004) 9463-9467
13. Balakrishnan B., Tzafriri A.R., Seifert P., et al. Strut position, blood flow, and drug deposition. Circulation 111 (2005) 2958-2965
14. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
15. Lerman A. Restenosis: another "dysfunction" of the endothelium. Circulation 111 (2005) 8-10
16. Rodriguez-Granillo G.A., García-García H.M., Mc Fadden E.P., et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 46 (2005) 2038-2042
17. Burke A.P., Farb A., Malcom G.T., et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336 (1997) 1276-1282